In addition, CAMK4, which is a target protein for neurological diseases and cancer, has a desirable drug design value40,41, suggesting that CAMK4 may be a target for drugs with better potential for anti-hepatocarcinoma. Here, CAMK4 is linked to nervous system disorder.